Motoric cognitive risk syndrome and risk of mortality in older adults.

TitleMotoric cognitive risk syndrome and risk of mortality in older adults.
Publication TypeJournal Article
Year of Publication2016
AuthorsAyers, E, Verghese, J
JournalAlzheimers Dement
Volume12
Issue5
Pagination556-64
Date Published2016 05
ISSN Number1552-5279
KeywordsAge Factors, Aged, Cognition Disorders, Cohort Studies, Dementia, Early Diagnosis, Female, Gait, Humans, Male, Mortality, Risk Factors
Abstract

INTRODUCTION: Cognitive impairment is associated with increased mortality. We examined the association between motoric cognitive risk (MCR) syndrome, a predementia syndrome characterized by slow gait and cognitive complaints, and survival.

METHODS: A total of 11,867 nondemented participants aged >65 years from three established cohort studies in the United States and Europe were screened for MCR. Mortality risk of MCR was assessed with Cox and logistic regression models.

RESULTS: At baseline, 836 (7.0%) participants had MCR. Over a median follow-up of 28 months, 1603 participants died (758 in first 2 years). MCR was associated with increased mortality overall (adjusted hazard ratio, 1.69; 95% confidence interval [CI], 1.46-1.96) and 2-year mortality (adjusted odds ratio, 1.89; 95% CI, 1.50-2.38). The association remained after accounting for established mortality risk factors as well as baseline gait speed and memory performance.

DISCUSSION: MCR is associated with increased mortality. Older adults should be screened for MCR to identify at-risk individuals for dementia and death.

URLhttps://www.ncbi.nlm.nih.gov/pubmed/26545790
DOI10.1016/j.jalz.2015.08.167
User Guide Notes

http://www.ncbi.nlm.nih.gov/pubmed/26545790?dopt=Abstract

Alternate JournalAlzheimers Dement
Citation Key8525
PubMed ID26545790
Grant ListU01 AG009740 / AG / NIA NIH HHS / United States
U01 AG032947 / AG / NIA NIH HHS / United States
P01 AG005842 / AG / NIA NIH HHS / United States
P01 AG008291 / AG / NIA NIH HHS / United States
P30 AG012815 / AG / NIA NIH HHS / United States
R21 AG025169 / AG / NIA NIH HHS / United States